Two Sigma Investments Portfolio holdings
AUM
$55.5B
1-Year Return
27.18%
This Quarter Return
+9.27%
1 Year Return
+27.18%
3 Year Return
+82.36%
5 Year Return
+135.75%
10 Year Return
+365.6%
AUM
$40.8B
AUM Growth
-$606M
(-1.5%)
Cap. Flow
-$4.84B
Cap. Flow
% of AUM
-11.86%
Top 10 Holdings %
Top 10 Hldgs %
9.42%
Holding
3,439
New
393
Increased
998
Reduced
1,370
Closed
505
Top Buys
| 1 |
Pfizer
PFE
|
$234M |
| 2 |
Gilead Sciences
GILD
|
$233M |
| 3 |
S&P Global
SPGI
|
$193M |
| 4 |
Nike
NKE
|
$185M |
| 5 |
Consumers Staples Select Sector SPDR Fund
XLP
|
$183M |
Top Sells
| 1 |
NVIDIA
NVDA
|
$380M |
| 2 |
Rivian
RIVN
|
$258M |
| 3 |
Advanced Micro Devices
AMD
|
$248M |
| 4 |
Invesco QQQ Trust
QQQ
|
$239M |
| 5 |
Merck
MRK
|
$213M |
Sector Composition
| 1 | Technology | 16.02% |
| 2 | Healthcare | 12.1% |
| 3 | Consumer Discretionary | 11.58% |
| 4 | Financials | 10.99% |
| 5 | Industrials | 9.98% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
376
Neurocrine Biosciences
NBIX
$14.3B
| $21.8M | 0.05% |
157,780
-67,127
| -30% | -$9.26M |
|
377
NovoCure
NVCR
$1.41B
| $21.7M | 0.05% |
1,389,058
-81,406
| -6% | -$1.27M |
|
378
VeriSign
VRSN
$26.3B
| $21.5M | 0.05% |
113,549
+27,628
| +32% | +$5.24M |
|
379
Oshkosh
OSK
$8.88B
| $21.4M | 0.05% |
171,518
-135,667
| -44% | -$16.9M |
|
380
Ares Capital
ARCC
$15.8B
| $21.2M | 0.05% |
1,019,915
-3,308,819
| -76% | -$68.9M |
|
381
VF Corp
VFC
$6.04B
| $21.2M | 0.05% |
1,383,631
+1,230,526
| +804% | +$18.9M |
|
382
iShares Russell Top 200 Growth ETF
IWY
$15B
| $21.1M | 0.05% |
108,300
+5,600
| +5% | +$1.09M |
|
383
IDEAYA Biosciences
IDYA
$2.06B
| $21.1M | 0.05% |
479,921
+409,452
| +581% | +$18M |
|
|
VRN
384
DELISTED
Veren
VRN
| $21M | 0.05% |
2,567,595
-316,042
| -11% | -$2.59M |
|
385
Allegion
ALLE
$14.8B
| $20.7M | 0.05% |
153,665
+88,833
| +137% | +$12M |
|
386
Archer Daniels Midland
ADM
$29.8B
| $20.7M | 0.05% |
329,311
+312,298
| +1,836% | +$19.6M |
|
387
Corcept Therapeutics
CORT
$7.53B
| $20.6M | 0.05% |
818,475
+340,918
| +71% | +$8.59M |
|
|
ALPN
388
DELISTED
Alpine Immune Sciences, Inc. Common Stock
ALPN
| $20.6M | 0.05% |
519,971
+141,558
| +37% | +$5.61M |
|
389
Qiagen
QGEN
$10.3B
| $20.4M | 0.05% |
461,424
+412,288
| +839% | +$18.2M |
|
390
Huntsman Corp
HUN
$1.94B
| $20.4M | 0.05% |
782,720
-104,387
| -12% | -$2.72M |
|
391
J.M. Smucker
SJM
$11.9B
| $20.1M | 0.05% |
159,871
-26,209
| -14% | -$3.3M |
|
392
CarMax
KMX
$9.19B
| $20.1M | 0.05% |
230,836
+40,658
| +21% | +$3.54M |
|
393
Guess, Inc.
GES
$880M
| $19.8M | 0.05% |
629,472
-89,209
| -12% | -$2.81M |
|
394
Kanzhun
BZ
$11.1B
| $19.8M | 0.05% |
1,129,789
+855,606
| +312% | +$15M |
|
395
Hexcel
HXL
$5.11B
| $19.8M | 0.05% |
271,517
+133,232
| +96% | +$9.71M |
|
396
RxSight
RXST
$363M
| $19.8M | 0.05% |
383,131
+102,819
| +37% | +$5.3M |
|
397
Texas Roadhouse
TXRH
$11.1B
| $19.7M | 0.05% |
127,267
+113,267
| +809% | +$17.5M |
|
398
Quest Diagnostics
DGX
$20.3B
| $19.6M | 0.05% |
+147,607
| New | +$19.6M |
|
399
Stryker
SYK
$150B
| $19.6M | 0.05% |
54,706
-63,623
| -54% | -$22.8M |
|
400
B2Gold
BTG
$5.68B
| $19.4M | 0.05% |
7,443,581
+443,803
| +6% | +$1.16M |
|